Healthtech Startups

Medcom develops, sells, and maintains "Medcom," a smartphone designed specifically for medical institutions and healthcare providers. Founded in 2016, the company applies IT to address challenges faced by Japan's medical sector.

1 investor

Yukashikado provides personalized nutrition testing and customized supplement products tailored to individual nutritional needs. The company serves consumers seeking personalized nutrition through mail-in testing kits, mobile apps, and bespoke supplement products.

1 investor

ReEir is a Japanese company founded out of regenerative medicine and wound-care expertise, working in areas such as regenerative medicine, wound surgery, and foot/podiatric care. It is led by academics and industry figures with backgrounds in plastic surgery, regenerative medicine, and medical devices.

1 investor

JARMeC operates advanced-care animal hospitals that provide specialized veterinary medicine across 12 clinical departments, working in partnership with primary-care veterinary clinics. Founded in 2005, it offers 365-day emergency and referral care for pets in Japan.

1 investor

Soiken Holdings is a biotech venture originating from Osaka University's medical faculty that develops and commercializes biomarker technologies and systems for objective health assessment across food, pharmaceutical, and healthcare applications.

1 investor

Shenzhen CoreTech Medical develops and manufactures artificial hearts and mechanical circulatory support devices for patients with advanced refractory heart failure. Its Corheart 6 implantable left ventricular assist system is a compact, fully magnetically levitated artificial heart approved by China's NMPA.

1 investor

Bushu Pharma is a contract development and manufacturing organization (CDMO) that provides contract manufacturing of pharmaceutical products, with GMP certifications from major countries and exports to 56 nations. It serves pharmaceutical clients as a specialist in outsourced drug manufacturing for global markets.

1 investor

Resverlogix is a late-stage clinical biotechnology company developing epigenetic therapeutics for patients with chronic illnesses and high unmet medical need. It also offers value-based health solutions to stakeholders such as payer groups.

1 investor

MedChemExpress (Shanghai Haoyuan Pharmaceutical, stock code 688131) is a CRO and CDMO that provides life-science research reagents and drug development, process optimization, and commercial manufacturing of APIs, intermediates, starting materials, and formulations for the global pharmaceutical and biotech industry. It offers an integrated platform covering small molecules, large molecules, and new molecular types from preclinical stages through commercial production.

1 investor

Sinocelltech is a biopharmaceutical company founded in 2002 that develops biologic drugs, with five products approved in China and nine additional candidates in clinical development. It is publicly listed in China (stock code 688520).

1 investor

Santo Biopharma is a drug development company building next-generation lentiviral vector in vivo gene therapies for rare diseases and cancer, including neurofibromatosis, meningioma, and malignant mesothelioma. It develops a fifth-generation lentiviral vector delivery system and serum-free production platforms to support gene therapy research.

1 investor

Kubota Holdings is an ophthalmic healthcare solutions company focused on developing pharmaceuticals and medical devices to help maintain and restore vision for people with eye diseases. The group engages in the research and development of treatments and medical technologies for ocular conditions.

1 investor

Uni-medica develops automated fluorescence staining and analysis systems, nucleic acid detection kits, and high-throughput sequencing products for molecular diagnostic applications including cervical cancer screening, pathogen detection, and genetic disease identification. The company serves hospitals and medical laboratories in China.

1 investor

Jiangsu Aidea Pharmaceutical Group is a Chinese pharmaceutical company that develops, manufactures, and sells innovative drugs, focusing on anti-HIV/AIDS therapeutics and prevention as well as human-derived protein biopharmaceuticals. Founded in 2009 and listed on the Shanghai Stock Exchange STAR Market (688488.SH), it operates an integrated human-protein industry chain in China.

1 investor

Suzhou Meichuang Medical Technology develops, manufactures, and commercializes high-end medical devices focused on peripheral vascular intervention, tumor/oncology intervention, and hemodialysis access. It aims to provide innovative medical device solutions for patients in China and globally.

1 investor

A Chinese in-vitro diagnostics company that develops diagnostic instruments and reagents, including chemiluminescence immunoassay analyzers, nucleic acid (PCR) testing systems, and fluorescence immunoassay analyzers for clinical and medical laboratories. The company focuses on in-house R&D of core reagent raw materials, open instrument platforms, and reagent solutions.

1 investor

Westlake Omics develops FAXP spatial proteomics technology, which uses tissue volume expansion to improve the quantity and quality of protein identifications while reducing analysis time. The technology targets applications in precision medicine and disease diagnosis.

1 investor

Novlead (诺令生物) develops inhaled nitric oxide (iNO) therapy and diagnostic systems for cardiopulmonary disease, covering nitric oxide generation, delivery, detection, storage, and clinical use across ICU, inpatient, outpatient, and home-care settings. Founded in 2018, it serves hospitals and patients, with products deployed in over 800 hospitals across China and commercialized in 10 countries including France and Hungary.

1 investor

Guizhou Sanli is a traditional Chinese medicine pharmaceutical company covering cultivation, R&D, production, and marketing, producing TCM in 16 dosage forms such as sprays, granules, capsules, pills, and tablets across GMP production lines. Founded in 1995, it is publicly listed on the Shanghai Stock Exchange and operates about ten subsidiaries.

1 investor

Shenzhen Jifu Medical Technology develops magnetically controlled capsule endoscopy systems for gastrointestinal examination, used in hospital digestive/gastroenterology settings. Its capsule endoscope products serve medical diagnostics in China.

1 investor

Chorakuchoju (超楽長寿) is a Japanese healthcare venture addressing social isolation among people aged 50 and older, combining psychiatry, behavioral economics (nudge theory), and AI in its service design. It operates Hahalol, a dating and marriage matchmaking app for the 50-plus demographic aimed at reducing loneliness and its associated health risks.

1 investor

Da An Gene is a Chinese state-owned biomedical company focused on molecular diagnostics, developing and producing clinical diagnostic reagents, instruments, and consumables, with a specialty in fluorescent PCR diagnostic reagents. Listed on the Shenzhen Stock Exchange (SZ002030), it serves clinical and in-vitro diagnostics markets and distributes products across many countries.

1 investor

Mindray develops medical devices for hospitals and clinicians, including the N-Series patient monitors designed for high-acuity care with modular hardware and connectivity features. It serves healthcare providers across various care settings worldwide.

1 investor

Suzhou Zumax Medical develops medical optical instruments including surgical microscopes, microscope accessories, dental surgical loupes, and medical headlamps for use in dentistry, neurosurgery, ENT, hand/orthopedic/plastic surgery, and ophthalmology. It sells to universities, public hospitals, and private clinics.

1 investor